{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:47:44Z","timestamp":1777952864103,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030732","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.gastrohep.2025.502646","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T16:12:08Z","timestamp":1766247128000},"page":"502646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Manejo de la proctitis ulcerosa refractaria"],"prefix":"10.1016","volume":"49","author":[{"given":"Manuel","family":"Barreiro-de Acosta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Mesonero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Ferreiro-Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Garc\u00eda-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Aguas Peris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Sierra Aus\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noelia","family":"Cano Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Valdivia Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"C\u00e1bez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Ginard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2025.502646_bib0345","first-page":"87","article-title":"Therapeutic requirements for maintenance of clinical remission in ulcerative proctitis","volume":"15","author":"Calafat","year":"2016","journal-title":"Enferm Inflam Intest Dia."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0350","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212505","article-title":"Epidemiology and hospital resources use in the treatment of ulcerative colitis at gastroenterology units in Spain (EPICURE study)","volume":"7","author":"Mar\u00edn-Jim\u00e9nez","year":"2018","journal-title":"Drugs Context."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0355","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/14712598.2024.2369189","article-title":"Management of proctitis in ulcerative colitis and the place of biological therapies","volume":"24","author":"De Deo","year":"2024","journal-title":"Expert Opin Biol Ther."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0360","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1572-0241.2000.t01-1-01770.x","article-title":"The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII)","volume":"95","author":"Meucci","year":"2000","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0365","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.2174\/138945011796818117","article-title":"Natural history of ulcerative colitis: current knowledge","volume":"12","author":"Kiss","year":"2011","journal-title":"Curr Drug Targets."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0370","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/00365520802600961","article-title":"Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)","volume":"44","author":"Solberg","year":"2009","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0375","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology."},{"issue":"Suppl 1","key":"10.1016\/j.gastrohep.2025.502646_bib0380","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.gastrohep.2023.01.009","article-title":"GADECCU 2022 Guideline for the treatment of Ulcerative Colitis. Adaptation and updating of the GETECCU 2020 Guideline","volume":"46","author":"Fuxman","year":"2023","journal-title":"Gastroenterol Hepatol."},{"issue":"Suppl 1","key":"10.1016\/j.gastrohep.2025.502646_bib0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gastrohep.2020.07.001","article-title":"GETECCU 2020 guidelines for the treatment of ulcerative colitis. Developed using the GRADE approach","volume":"43","author":"Sicilia","year":"2020","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502646_bib0390","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J Crohns Colitis."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0395","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1177\/2050640620941345","article-title":"Long-term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort","volume":"8","author":"Dubois","year":"2020","journal-title":"United European Gastroenterol J."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0400","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000493979","article-title":"Tacrolimus Suppositories in Therapy-Resistant Ulcerative Proctitis","volume":"3","author":"Jaeger","year":"2019","journal-title":"Inflamm Intest Dis."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0405","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.18133","article-title":"Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry","volume":"60","author":"Ferreiro-Iglesias","year":"2024","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0410","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s10620-024-08276-1","article-title":"Effectiveness of Tofacitinib in Ulcerative Proctitis Compared to Left Sided Colitis and Pancolitis","volume":"69","author":"Singh","year":"2024","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0415","doi-asserted-by":"crossref","first-page":"i536","DOI":"10.1093\/ecco-jcc\/jjac190.0537","article-title":"Efficacy and safety of etrasimod in subjects with moderately to severely active isolated proctitis: a subgroup analysis of the phase 3 ELEVATE UC 52 and ELEVATE UC 12 trials","volume":"17","author":"Peyrin-Biroulet","year":"2023","journal-title":"J Crohns Colitis."},{"issue":"10218","key":"10.1016\/j.gastrohep.2025.502646_bib0420","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(19)32545-0","article-title":"Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study","volume":"395","author":"Olen","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0425","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0435","author":"Wells","year":"2009","journal-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0440","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0445","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1177\/1049732302238251","article-title":"Appraising the evidence: reviewing disparate data systematically","volume":"12","author":"Hawker","year":"2002","journal-title":"Qual Health Res."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0450","year":"2025","journal-title":"2011 OCEBM Levels of Evidence 2011"},{"key":"10.1016\/j.gastrohep.2025.502646_bib0455","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0016-5085(91)90202-V","article-title":"The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden","volume":"100","author":"Ekbom","year":"1991","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0460","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/MEG.0b013e3280110fb9","article-title":"Change of clinical characteristics of ulcerative colitis in Japan: analysis of 844 hospital-based patients from 1981 to 2000","volume":"19","author":"Fujimoto","year":"2007","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0465","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/jgh.13596","article-title":"Overall and cause-specific mortality in Korean patients with inflammatory bowel disease: A hospital-based cohort study","volume":"32","author":"Lee","year":"2017","journal-title":"J Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0470","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/ecco-jcc\/jjz096","article-title":"Direct and Indirect Costs of Inflammatory Bowel Disease: Ten Years of Follow-up in a Danish Population-based Inception Cohort","volume":"14","author":"Lo","year":"2020","journal-title":"J Crohns Colitis."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0475","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MEG.0000000000001326","article-title":"Acetarsol in the management of mesalazine-refractory ulcerative proctitis: a tertiary-level care experience","volume":"31","author":"Argyriou","year":"2019","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0480","doi-asserted-by":"crossref","first-page":"357","DOI":"10.5217\/ir.2023.00106","article-title":"Changes in the clinical course and prognosis of ulcerative colitis in Chinese populations: a retrospective cohort study","volume":"22","author":"Liu","year":"2024","journal-title":"Intest Res."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0485","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.cgh.2019.05.060","article-title":"Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis","volume":"18","author":"Pineton de Chambrun","year":"2020","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0490","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/ecco-jcc\/jjx009","article-title":"Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management","volume":"11","author":"Harbord","year":"2017","journal-title":"J Crohns Colitis."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0495","first-page":"58","article-title":"Clinical Significance of Isolated Peri-Appendiceal Lesions in Patients With Left Sided Ulcerative Colitis","volume":"4","author":"Bakman","year":"2011","journal-title":"Gastroenterology Res."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0500","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1038\/ajg.2009.388","article-title":"Appendicectomy as a therapy for ulcerative proctitis","volume":"104","author":"Bolin","year":"2009","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0505","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1365-2036.2010.04293.x","article-title":"Infliximab for refractory ulcerative proctitis","volume":"31","author":"Bouguen","year":"2010","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0510","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/jgh3.12280","article-title":"Simple water-based tacrolimus enemas for refractory proctitis","volume":"4","author":"Fehily","year":"2020","journal-title":"JGH Open."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0515","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1365-2036.2008.03841.x","article-title":"Rectal tacrolimus in the treatment of resistant ulcerative proctitis","volume":"28","author":"Lawrance","year":"2008","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0520","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cgh.2023.06.023","article-title":"Outcome of Biological Therapies and Small Molecules in Ulcerative Proctitis: A Belgian Multicenter Cohort Study","volume":"22","author":"Lemmens","year":"2024","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0525","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/flgastro-2017-100888","article-title":"Tacrolimus therapy in moderate to subacute ulcerative proctocolitis: a large single-centre cohort study","volume":"9","author":"Saifuddin","year":"2018","journal-title":"Frontline Gastroenterol."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0530","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/ecco-jcc\/jjad169","article-title":"Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAID","volume":"18","author":"Uzzan","year":"2024","journal-title":"J Crohns Colitis."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0535","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000533543","article-title":"Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis","volume":"8","author":"Uchiyama","year":"2023","journal-title":"Inflamm Intest Dis."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0540","doi-asserted-by":"crossref","first-page":"e001139","DOI":"10.1136\/bmjgast-2023-001139","article-title":"Delphi consensus survey: the opinions of patients living with refractory ulcerative proctitis and the health care professionals who care for them","volume":"10","author":"Kyriacou","year":"2023","journal-title":"BMJ Open Gastroenterol."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0545","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study","volume":"317","author":"Schroeder","year":"1987","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0550","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s41687-022-00439-w","article-title":"Incorporating patient experience into drug development for ulcerative colitis: development of the Urgency Numeric Rating Scale, a patient-reported outcome measure to assess bowel urgency in adults","volume":"6","author":"Dubinsky","year":"2022","journal-title":"J Patient Rep Outcomes."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0555","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cgh.2017.02.027","article-title":"Efficacy of Rectal Tacrolimus for Induction Therapy in Patients With Resistant Ulcerative Proctitis","volume":"15","author":"Lawrance","year":"2017","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0560","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.cgh.2019.09.049","article-title":"No Superiority of Tacrolimus Suppositories vs Beclomethasone Suppositories in a Randomized Trial of Patients With Refractory Ulcerative Proctitis","volume":"18","author":"Lie","year":"2020","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0565","doi-asserted-by":"crossref","first-page":"jjaf058","DOI":"10.1093\/ecco-jcc\/jjaf058","article-title":"Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study of GETECCU","volume":"19","author":"Fuentes-Valenzuela","year":"2025","journal-title":"J Crohns Colitis."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0570","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.dld.2016.12.001","article-title":"Azathioprine for refractory ulcerative proctitis: A retrospective multicenter study","volume":"49","author":"Mallet","year":"2017","journal-title":"Dig Liver Dis."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0575","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S2468-1253(25)00026-3","article-title":"Appendicectomy plus standard medical therapy versus standard medical therapy alone for maintenance of remission in ulcerative colitis (ACCURE): a pragmatic, open-label, international, randomised, trial","volume":"10","year":"2025","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0580","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cgh.2014.07.055","article-title":"A panel to predict long-term outcome of infliximab therapy for patients with ulcerative colitis","volume":"13","author":"Arias","year":"2015","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0585","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.MIB.0000195391.49762.89","article-title":"Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health","volume":"12","author":"Farrokhyar","year":"2006","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0590","doi-asserted-by":"crossref","first-page":"13513","DOI":"10.1038\/s41598-024-63893-0","article-title":"Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals","volume":"14","author":"Heinzel","year":"2024","journal-title":"Sci Rep."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0595","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/00365521.2019.1566493","article-title":"Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopy","volume":"54","author":"Lundgren","year":"2019","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0600","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/imj.13965","article-title":"Multidisciplinary team meetings appear to be effective in inflammatory bowel disease management: an audit of process and outcomes","volume":"48","author":"Ferman","year":"2018","journal-title":"Intern Med J."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0605","article-title":"Confederaci\u00f3n de Crohn y Colitis ulcerosa","year":"2025","journal-title":"Confederaci\u00f3n ACCU Espa\u00f1a"},{"key":"10.1016\/j.gastrohep.2025.502646_bib0610","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/00365521.2020.1757143","article-title":"Acute severe attacks of ulcerative colitis in a population-based cohort: epidemiology, treatment and outcome","volume":"55","author":"R\u00f6nnblom","year":"2020","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0615","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1136\/gutjnl-2016-311970","article-title":"Ulcerative proctitis is a frequent location of paediatric-onset UC and not a minor disease: a population-based study","volume":"66","author":"Hochart","year":"2017","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0620","first-page":"149","article-title":"Clinical outcome of ulcerative proctitis in children","volume":"25","author":"Hyams","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0625","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-230X-6-21","article-title":"Factors associated with disease evolution in Greek patients with inflammatory bowel disease","volume":"6","author":"Chatzicostas","year":"2006","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0630","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.dld.2023.07.008","article-title":"Disease course of ulcerative proctitis in children: A population-based study on behalf of the SIGENP IBD Group","volume":"56","author":"Martinelli","year":"2024","journal-title":"Dig Liver Dis."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0635","doi-asserted-by":"crossref","first-page":"O97","DOI":"10.1111\/codi.13237","article-title":"Clinical pattern and progression of ulcerative proctitis in the Japanese population: a retrospective study of incidence and risk factors influencing progression","volume":"18","author":"Anzai","year":"2016","journal-title":"Colorectal Dis."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0640","doi-asserted-by":"crossref","first-page":"320","DOI":"10.5152\/tjg.2022.21124","article-title":"Factors Predictive of Proximal Disease Extension and Clinical Course of Patients Initially Diagnosed with Ulcerative Proctitis in an IBD Referral Center","volume":"33","author":"da Costa Ferreira","year":"2022","journal-title":"Turk J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0645","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/MIB.0000000000001214","article-title":"Clinical Predictors and Natural History of Disease Extension in Patients with Ulcerative Proctitis","volume":"23","author":"Walsh","year":"2017","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0650","doi-asserted-by":"crossref","first-page":"O278","DOI":"10.1111\/codi.13435","article-title":"Appendiceal orifice inflammation is associated with proximal extension of disease in patients with ulcerative colitis","volume":"18","author":"Anzai","year":"2016","journal-title":"Colorectal Dis."},{"issue":"10-11","key":"10.1016\/j.gastrohep.2025.502646_bib0655","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1080\/00365521.2018.1524026","article-title":"Endoscopic progression of ulcerative proctitis to proximal disease. Can we identify predictors of progression?","volume":"53","author":"Huguet","year":"2018","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0660","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/00054725-200411000-00006","article-title":"Oral mesalazine (5-ASA) treatment may protect against proximal extension of mucosal inflammation in ulcerative proctitis","volume":"10","author":"Pica","year":"2004","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0665","doi-asserted-by":"crossref","first-page":"208","DOI":"10.12968\/bjon.2007.16.4.22979","article-title":"Contribution of specialist nurses in managing patients with IBD","volume":"16","author":"Younge","year":"2007","journal-title":"Br J Nurs."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0670","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/nursrep11020023","article-title":"Inflammatory Bowel Disease Nurse-Practical Messages","volume":"11","author":"Rosso","year":"2021","journal-title":"Nurs Rep."},{"key":"10.1016\/j.gastrohep.2025.502646_bib0675","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02050307","article-title":"Etiology and management of fecal incontinence","volume":"36","author":"Jorge","year":"1993","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.gastrohep.2025.502646_bib0680","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s41687-018-0049-2","article-title":"Development and validation of the Ulcerative Colitis patient-reported outcomes signs and symptoms (UC-pro\/SS) diary","volume":"2","author":"Higgins","year":"2017","journal-title":"J Patient Rep Outcomes."}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570525005163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570525005163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:17:53Z","timestamp":1777900673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570525005163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0210570525005163"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2025.502646","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manejo de la proctitis ulcerosa refractaria","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2025.502646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"502646"}}